Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.

Poletto, Stefano; Paruzzo, Luca; Nepote, Alessandro; Caravelli, Daniela; Sangiolo, Dario; Carnevale-Schianca, Fabrizio

Poletto, Stefano; Paruzzo, Luca; Nepote, Alessandro; Caravelli, Daniela; Sangiolo, Dario; Carnevale-Schianca, Fabrizio.

Afiliação

Poletto S; Department of Oncology, University of Turin, AOU S. Luigi Gonzaga, 10043 Orbassano, Italy.
Paruzzo L; Department of Oncology, University of Turin, 10124 Turin, Italy.
Nepote A; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Caravelli D; Department of Oncology, University of Turin, AOU S. Luigi Gonzaga, 10043 Orbassano, Italy.
Sangiolo D; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, 10060 Candiolo, Italy.
Carnevale-Schianca F; Department of Oncology, University of Turin, 10124 Turin, Italy.

Cancers (Basel) ; 16(1)2023 Dec 24.

Article em En | MEDLINE | ID: mdl-38201531

Palavras-chave

biomarker; immune checkpoint inhibitors; immunotherapy; melanoma; predictive factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google